One key aspect of human aging is the dysregulation of the immune system. As we age, our body's defense system weakens, leading to declined responses to infection by new pathogens and a decreased ability to become immunized (Goronzy and Weyand, 2013; Goronzy and Weyand, 2017). As a result, elderly people are more susceptible to the seasonal flu caused by the constantly mutating influenza viruses. Another manifestation of immune system aging is low grade chronic inflammation, which is linked to many age-related diseases (Glass et al., 2010; Ferrucci and Fabbri, 2018). Recent comprehensive characterization of cellular and molecular changes caused by aging in mammals further revealed the importance of immune system aging, as the up-regulation of genes involved in the inflammatory/immune response turned out to be a highly conserved signature across species and across different organs and tissues (Frenk and Houseley, 2018; Ma et al., 2020; Schaum et al., 2020; Tabula Muris, 2020). In addition, senolytic drugs targeting senescent cells which is a source of chronic inflammation showed great promise in retarding/ preventing many age-related pathologies (Kirkland and Tchkonia, 2020). With the raging COVID-19 pandemic ongoing, the interaction between aging and immune response to the pathogen SARS-CoV-2 has attracted great attention. It has been widely reported that elderly people are more susceptible to COVID-19 and, once infected, the consequence is much more severe. Among the infected, there is a higher rate of admission to ICU and higher rate of death for people aged 65 or older (Onder et al., 2020; Verity et al., 2020). The deaths associated with COVID-19 have been largely attributed to respiratory failure, sepsis, cardiac failure, kidney injury, or coagulopathy. Notably, substantial evidence suggests that in some patients the severity of the outcome is associated with dysregulated and excessive release of cytokines (Laing, 2020; Ye et al., 2020); such overreaction of